Mwanzo207940 • KRX
add
Samsung Biologics Co Ltd
Bei iliyotangulia
â‚©Â 1,034,000.00
Bei za siku
â‚©Â 1,015,000.00 - â‚©Â 1,040,000.00
Bei za mwaka
â‚©Â 722,000.00 - â‚©Â 1,209,000.00
Thamani ya kampuni katika soko
72.53T KRW
Wastani wa hisa zilizouzwa
elfu 80.03
Uwiano wa bei na mapato
56.68
Mgao wa faida
-
Habari za soko
.DJI
1.05%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 1.30T | 37.11% |
Matumizi ya uendeshaji wa biashara | 241.41B | 22.51% |
Mapato halisi | 375.55B | 109.38% |
Kiwango cha faida halisi | 28.93 | 52.75% |
Mapato kwa kila hisa | elfu 5.28 | 109.40% |
EBITDA | 650.09B | 78.25% |
Asilimia ya kodi ya mapato | 24.80% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.29T | -37.61% |
Jumla ya mali | 17.44T | 5.53% |
Jumla ya dhima | 6.16T | -5.47% |
Jumla ya hisa | 11.28T | — |
hisa zilizosalia | 71.17M | — |
Uwiano wa bei na thamani | 6.52 | — |
Faida inayotokana na mali | 7.00% | — |
Faida inayotokana mtaji | 9.70% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(KRW) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 375.55B | 109.38% |
Pesa kutokana na shughuli | 682.98B | 135.64% |
Pesa kutokana na uwekezaji | -250.22B | -142.78% |
Pesa kutokana na ufadhili | -69.80B | 65.49% |
Mabadiliko halisi ya pesa taslimu | 360.84B | -47.87% |
Mtiririko huru wa pesa | -103.14B | -115.61% |
Kuhusu
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2011
Tovuti
Wafanyakazi
4,770